Marianne de Backer - 01 Dec 2021 Form 4 Insider Report for Kronos Bio, Inc. (KRON)

Role
Director
Signature
/s/ Allison Frisbee, Attorney-in-Fact
Issuer symbol
KRON
Transactions as of
01 Dec 2021
Net transactions value
+$13,306
Form type
4
Filing time
02 Dec 2021, 16:12:07 UTC
Previous filing
24 Aug 2021
Next filing
04 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRON Common Stock Purchase $13,306 +1,150 +72% $11.57* 2,750 01 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The weighted average purchase price for the transaction reported was $11.57, and the range of prices were between $11.38 and $11.79. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.